Go Pro

MetLife (MET) Stock Forecast & Price Target

MetLife logo
$97.16 -0.04 (-0.04%)
Closing price 03:59 PM Eastern
Extended Trading
$97.25 +0.09 (+0.09%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MetLife - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
0
Buy
12

Based on 12 Wall Street analysts who have issued ratings for MetLife in the last 12 months, the stock has a consensus rating of "Buy." Out of the 12 analysts, 12 have given a buy rating for MET.

Consensus Price Target

$104.31
7.36% Upside
According to the 12 analysts' twelve-month price targets for MetLife, the average price target is $104.31. The highest price target for MET is $111.00, while the lowest price target for MET is $96.00. The average price target represents a forecasted upside of 7.36% from the current price of $97.16.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MET and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for MetLife and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MET Analyst Ratings Over Time

TypeCurrent Forecast
9/24/25 to 9/24/26
1 Month Ago
8/25/25 to 8/25/26
3 Months Ago
6/26/25 to 6/26/26
1 Year Ago
9/24/24 to 9/24/25
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
12 Buy rating(s)
11 Buy rating(s)
11 Buy rating(s)
8 Buy rating(s)
Hold
0 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$104.31$102.21$95.62$94.64
Forecasted Upside7.36% Upside6.57% Upside11.09% Upside17.33% Upside
Consensus RatingBuyBuyModerate BuyModerate Buy

MET Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MET Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

MetLife Stock vs. The Competition

TypeMetLifeFinance CompaniesBroader Market
Consensus Rating Score
3.00
2.27
2.53
Consensus RatingBuyHoldModerate Buy
Predicted Upside6.76% Upside35.34% Upside19.25% Upside
News Sentiment Rating
Neutral News

See Recent MET News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/22/2026
Piper Sandler logo
Piper Sandler
2 of 5 stars
Paul Newsome
Paul Newsome
2 of 5 stars
UpgradeNeutral ➝ Overweight$99.00 ➝ $110.00+13.71%
9/11/2026
Weiss Ratings logo
Weiss Ratings
5 of 5 stars
 Reiterated RatingBuy (B)
8/24/2026
Evercore Inc logo
Evercore
3 of 5 stars
 Reiterated RatingMixed
8/24/2026Boost TargetOverweight$103.00 ➝ $111.00+16.15%
8/19/2026Boost TargetOverweight$101.00 ➝ $109.00+12.56%
8/11/2026Boost TargetOverweight$106.00 ➝ $108.00+11.40%
8/11/2026Boost TargetOutperform$105.00 ➝ $108.00+11.39%
8/6/2026Boost TargetOverweight$94.00 ➝ $97.00+0.57%
7/22/2026Boost TargetBuy$87.00 ➝ $105.00+11.84%
7/15/2026 Set Target$103.00+11.65%
7/10/2026Boost TargetBuy$97.00 ➝ $103.00+13.02%
7/9/2026Boost TargetOutperform$95.00 ➝ $102.00+13.22%
7/8/2026Boost TargetBuy$102.00 ➝ $105.00+15.60%
4/14/2026Lower TargetBuy$103.00 ➝ $99.00+29.81%
9/16/2025UpgradeStrong-Buy
1/23/2025Initiated CoverageMarket Perform$97.00+13.09%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:38 PM ET.


Should I Buy MetLife Stock? MET Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, September 20, 2026. Please send any questions or comments about these MetLife pros and cons to contact@marketbeat.com.

MetLife
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in MetLife, Inc.:

  • MetLife, Inc. recently announced a $3.00 billion stock buyback plan, a move that often signals the board of directors believes the stock is undervalued and aims to return capital to shareholders by reducing the number of outstanding shares.
  • The company demonstrated strong financial performance in its most recent quarter, reporting earnings per share of $2.43, which exceeded the consensus estimate of $2.30, while also achieving a return on equity of 23.39% and a net margin of 4.57%.
  • MetLife, Inc. offers a consistent income stream with a dividend yield of 2.44%, having recently paid a quarterly dividend of $0.5925 per share, which is attractive for investors seeking regular cash flow from their portfolio.
  • Analysts maintain a positive outlook on the stock, with a consensus rating of "Moderate Buy" and an average 12-month price target of $102.77, suggesting potential upside from the current trading levels.
  • The stock is currently trading at $97.08, which is below the 52-week high of $100.93, potentially offering a favorable entry point for investors looking to capitalize on the company's recent momentum and strong institutional ownership of nearly 95%.

MetLife
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in MetLife, Inc. for these reasons:

  • Recent analyst sentiment has shown some divergence, with Wall Street Zen downgrading the stock from "buy" to "hold" and Piper Sandler maintaining a "neutral" rating, indicating that some experts see limited near-term upside or increased risk.
  • MetLife, Inc. has a relatively high debt-to-equity ratio of 0.52, which means the company relies significantly on borrowed funds to finance its operations, potentially increasing financial risk during periods of economic uncertainty or rising interest rates.
  • The company's quick ratio and current ratio are both at 0.20, indicating that it has limited liquid assets to cover its short-term liabilities, which could pose challenges in meeting immediate financial obligations without accessing additional credit lines.
  • While the stock has performed well, it is trading near its 52-week high of $100.93, which may limit short-term price appreciation and increase the risk of a pullback if market conditions shift or if the company fails to meet future earnings expectations.
  • MetLife, Inc. operates in the highly competitive insurance and financial services sector, where regulatory changes, interest rate fluctuations, and economic downturns can significantly impact profitability and demand for its products, such as life insurance and annuities.

MET Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for MetLife is $104.31, with a high forecast of $111.00 and a low forecast of $96.00.

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MetLife in the last twelve months. There are currently 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MET shares.

According to analysts, MetLife's stock has a predicted upside of 7.36% based on their 12-month stock forecasts.

Over the previous 90 days, MetLife's stock had 1 upgrade by analysts.

Analysts like MetLife more than other "finance" companies. The consensus rating for MetLife is Buy while the average consensus rating for "finance" companies is Hold. Learn more on how MET compares to other companies.


MarketBeat monitors more than a dozen sources for MetLife analyst ratings, with the most recent rating issued on 9/22/2026.
From Our Partners